During the past decade, CAP El Remei conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "CAP El Remei" #1 collaborator was "Laboratorios del Dr. Esteve, S.A." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "CAP El Remei" are "Cardiovascular Disease" (2 trials), "Healthy" (1 trials) and "Ulcer" (1 trials). Many other conditions were trialed in "CAP El Remei" in a lesser frequency.

Most popular intervention types in "CAP El Remei" are "Drug" (3 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "bococizumab (PF-04950615)" (2 trials), "Calcium Dobesilate" (1 trials) and "rLP2086" (1 trials). Other intervention names were less common.

The vast majority of trials in "CAP El Remei" are 4 trials for "All" genders.

Currently, there are NaN active trials in "CAP El Remei". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in CAP El Remei, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in CAP El Remei, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".